Dow Sells Treflan, Edge Herbicides to Gowan

Gowan Company has announced a deal to acquire the entire DNA (dinitroaniline) herbicide portfolio from Dow AgroSciences, including popular herbicides Treflan and Edge.

The products to be acquired by Gowan have active registrations in 22 countries including the USA, Canada, Japan, Australia, and parts of Europe.

“We are enthusiastic to be able to acquire these proven products in this critical era for herbicide resistance management. The products are particularly significant for us in Canada and Europe where our growing sales force is centered on extending the utility of herbicide programs,” said Juli Jessen, Gowan Group CEO. “And we are grateful for the opportunity to defend and evolve the DNAs for niches that have long been our sweet spot, such as vegetables and turf.”

The deal includes Treflan, Edge, Team, Bonalan, Sonalan and intellectual property and labels for products containing trifluralin, benfluralin and ethalfluralin. A formulation and packaging facility in Sturgeon County, Alberta is part of the transaction.

Gowan also holds the Canadian registration for Avadex, a granular herbicide used to control resistant wild oats. Gowan acquired the herbicide from Monsanto in 2004.

While terms of the deal with Dow were not made public, it’s expected to close before the end of 2015.

Related: The Role of Soil-Applied Herbicides in Combating Resistance

 

RealAgriculture News Team

A team effort of RealAgriculture’s videographers and editorial staff to make sure that you have the latest in what is happening in agriculture.


Trending

Wheat Pete’s Word, Nov 22: Swimming in rain, sacrificing straw and parking the plow

In this episode of The Word, host Peter No-Till takes us through Ontario's wet conditions, zeroes in on soil health, discusses tillage, and answers some specific questions. Have a question you’d like Johnson to address? Or some yield results to send in? Leave him a message at 1-844-540-2014, send him a tweet (@wheatpete), or email…Read more »

Related

Leave a Reply